Journal of the Korean Ophthalmological Society

Search

Page Path

HOME
Search

Original Articles

Comparison of Treatment Outcomes Between the Ranibizumab Biosimilar CKD-701 and Bevacizumab in Idiopathic Choroidal Neovascularization: So Hyun Yu, Sang Min Park, Jae Hui Kim; J Korean Ophthalmol Soc. 2026;67(7):225-232. Published online July 15, 2026; DOI: https://doi.org/10.3341/jkos.2026.67.7.225; Full text PubReader ePub PDF

Short-term Clinical Outcomes of Ranibizumab Biosimilar SB11 Therapy in Neovascular Age-related Macular Degeneration: Dong Gyu Na, Chul Gu Kim, Jong Woo Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2025;66(5):224-232. Published online May 15, 2025; DOI: https://doi.org/10.3341/jkos.2025.66.5.224; Full text PubReader ePub PDF

Short-term Outcomes of Faricimab for Neovascular Age-related Macular Degeneration with Limited Response to Ranibizumab or Aflibercept: Jeongmin Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2024;65(8):515-524. Published online August 14, 2024; DOI: https://doi.org/10.3341/jkos.2024.65.8.515; Full text PubReader ePub PDF

Clinical Outcomes of Double-dose Aflibercept Treatment for Refractory Wet Age-related Macular Degeneration: Sung Hyun Jo, Han Jo Kwon, Sung Who Park, Ik Soo Byon; J Korean Ophthalmol Soc. 2024;65(8):500-507. Published online August 14, 2024; DOI: https://doi.org/10.3341/jkos.2024.65.8.500; Full text PubReader ePub PDF

Injection Frequency and Differences in Visual Outcomes based on Diagnosis Year in Neovascular Age-related Macular Degeneration: Kyoung Hae Kang, Chul Gu Kim, Jong Woo Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2024;65(2):117-124. Published online February 15, 2024; DOI: https://doi.org/10.3341/jkos.2024.65.2.117; Full text PubReader ePub PDF

Efficacy of Injection Interval Shortening in Neovascular Age-related Macular Degeneration with Limited Response to Bimonthly Aflibercept: Min Chul Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2023;64(8):700-708. Published online August 15, 2023; DOI: https://doi.org/10.3341/jkos.2023.64.8.700
Web of Science 1 Crossref 1; Full text PubReader ePub PDF

Long-term Outcomes of Myopic Choroidal Neovascularization and Retinal Changes according to ATN Classification: Sujin Yeo, Jong Min Kim; J Korean Ophthalmol Soc. 2023;64(6):514-521. Published online June 15, 2023; DOI: https://doi.org/10.3341/jkos.2023.64.6.514; Full text PubReader ePub PDF

Case Reports

Recurrent Idiopathic Choroidal Neovascularization in an Adolescent: Hayoung Lee, Jaehyuk Lee, Jongwon Moon; J Korean Ophthalmol Soc. 2023;64(2):158-163. Published online February 15, 2023; DOI: https://doi.org/10.3341/jkos.2023.64.2.158; Full text PubReader ePub PDF

Original Articles

Outcome of Aflibercept-Bevacizumab Alternate Dosing in Neovascular Age-related Macular Degeneration with Limited Response to Aflibercept: Daeun Shin, Jae Hui Kim; J Korean Ophthalmol Soc. 2022;63(6):526-534. Published online June 15, 2022; DOI: https://doi.org/10.3341/jkos.2022.63.6.526
Web of Science 1 Crossref 1; Full text PubReader ePub PDF

Proportion of and Reason for Bevacizumab Usage in the Treatment of Wet Age-related Macular Degeneration: Yi Sang Yoon, Won Tae Yoon, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2021;62(8):1076-1083. Published online August 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.8.1076
Web of Science 3 Crossref 5; Full text PubReader ePub PDF

Diagnostic Availability of Optical Coherence Angiography in Type 1 and 2 Choroidal Neovascularization: Da Yeong Kim, Ki Seok Kim, Jie Hyun Youm; J Korean Ophthalmol Soc. 2021;62(3):345-353. Published online March 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.3.345; Full text PubReader ePub PDF

Clinical Outcomes after Switching from As-needed to Proactive Injections in the Neovascular Age-related Macular Degeneration: Soo Hyun Lim, Jae Hyung Hwang, Jong Woo Kim, Chul Gu Kim, Dong Won Lee, Jae Hui Kim; J Korean Ophthalmol Soc. 2020;61(6):630-638. Published online June 15, 2020; DOI: https://doi.org/10.3341/jkos.2020.61.6.630; Full text PubReader ePub PDF

Case Reports

Anti-Vascular Endothelial Growth Factor Therapy for Choroidal Neovascularization Secondary to Optic Nerve Head Drusen.: Ka Hee Park; J Korean Ophthalmol Soc. 2019;60(12):1369-1373. Published online December 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.12.1369; PDF

Choroidal Neovascularization in a Patient with Best Disease.: Jae Uk Jung, Yu Min Kim, Yong Koo Kang, Dong Ho Park, Jae Pil Shin; J Korean Ophthalmol Soc. 2019;60(8):808-815. Published online August 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.8.808
Web of Science 1 Crossref 1; PDF

Original Articles

Long-term Treatment Outcomes of Intravitreal Bevacizumab Treatment for Myopic Choroidal Neovascularization.: Jeong Min Lee, Jong Woo Kim, Dong Won Lee, Jae Hui Kim; J Korean Ophthalmol Soc. 2019;60(6):547-554. Published online June 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.6.547
Web of Science 2 Crossref 5; PDF

Volume 67, No. 8

Journal of
the Korean
Ophthalmological
Society

Print ISSN: 0378-6471
Online ISSN: 2092-9374

Impact Factor

0.1

MOST VIEWED MOST CITED

3,442	Efficacy of 1% Ivermectin Ointment for Demodex Blepharitis
7,594	Self-assessment of Visual Acuity Using a Smartphone Application
5,365	Accuracy of Intraocular Lens Power Prediction Using 9 Formula
3,476	Long-term Effects of Wearing Orthokeratology Lenses for More than 5 Years on the Progression of Childhood Myopia
3,742	Central Anticholinergic Syndrome Induced by Atropine Eye Drops: A Case Report

Cited By 4	The Effect of Topical Rebamipide 2% in Managing Dry Eye Following Cataract Surgery
Cited By 3	A Case of Retinal Vasculitis, Uveitis in Myelin Oligodendrocyte Glycoprotein Antibody Associated Optic Neuritis
Cited By 3	Short-term Outcomes of Ranibizumab Biosimilar CKD-701 Treatment in Macular Edema Secondary to Retinal Vein Occlusion
Cited By 2	What Laboratory Examinations for Open-angle Glaucoma Risk Stratification
Cited By 2	Comparison of Clinical Outcomes Among Sutured, Sutureless Scleral Fixation, and Retropupillary Fixation of Intraocular Lens

Editorial Office: #1001, Jeokseon Hyundai BD
130, Sajik-ro, Jongno-gu, Seoul 03170, Korea
Tel: +82-2-2271-6603 Fax: +82-2-2277-5194 E-mail: kos@ijpnc.com

Copyright © 2026 by Korean Ophthalmological Society.

prev

next